SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63388 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
61307I owned it for a while but sold at a small loss when initial sales were poor. Bistockdoc77211/15/2022
61306I have had a position for a while (bought at $13.00 ps!!!) Like the prospects. sysiphus-11/15/2022
61305Adding to the discussion on the roles of soluble vs. non-soluble a-beta in neuroweatherproof-11/15/2022
61304Anyone here invested in MRNS? I know Avoro has had a stake for a while, but sawIMMUzombie-11/15/2022
61303Yes, that hypothesis is coming from Espay. Two things to keep in mind: 1. As weatherproof-11/15/2022
61302Based on the unequivocal failure of the amyloid hypothesis, Neurologist/Biologisghettogoulash-11/14/2022
61301SAVA vs AVXL is simple and MOA is academic here.... the bottom line question is scorman1211/14/2022
61300SAVA case against shorts: Short sellers hit back at Cassava lawsuit against theerickerickson-11/14/2022
61299What are your thoughts on Aurinia?plhky3465-11/14/2022
61298>>so FOMO keeps me in, albeit less than 1% of net worth.<< So, yourweatherproof111/14/2022
61297FWIW weather ( hope you are doing well ) had the same thoughts as you, I decidedzevenhuizen-11/14/2022
61296The MOA as explained by SAVA is a lot of handwaving. I have no idea if it is lestockdoc77211/14/2022
61295>>with my takeaway that Cassava's Simufilam is indirectly accomplishinweatherproof-11/14/2022
61294Avoro 9/30 [graphic]sysiphus111/14/2022
61293As you noted, that paper is 10 years old. I guess I'm just trying to reconcweatherproof-11/14/2022
61292endpts.comsysiphus-11/14/2022
61291Interestingly, this study does not identify the misfolded variety of FLNA. I imaghettogoulash-11/13/2022
61290The company puts more of an emphasis on eliminating the toxic signaling of AB42-ghettogoulash-11/13/2022
61289By the way, I'm wondering if some of you SAVAges can weigh in on my sense thweatherproof211/13/2022
61288>>And yes, they are indeed biomarkers. But what good is early diagnosis ofweatherproof-11/13/2022
61287I can only speak for Simufilam and similar nouveau research. Maybe Anavex is amoghettogoulash-11/13/2022
61286That post was epic, Fitz. Thanks. It just so happens to fit perfectly with my thghettogoulash-11/13/2022
61285When I think of a treatment that helps reduce production of plaque as well as reweatherproof211/12/2022
61284Up 7%. Biggest dollar gain in a single day for me other than when IMMU got bougstockdoc77811/10/2022
61283Dearest Ghetto: I think that many of your inferences are correct. As you mayFitzhughlaw1611/10/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News